top of page
The Sage Group is attending Bio Partnering at JPM in
San Francisco from
January 12-15, 2026! Please click here to meet!
See Latest News!
GLOBAL LIFE SCIENCES DEALMAKERS: 30+ YEARS. 300+ CLIENTS & TRANSACTIONS. BILLIONS IN VALUE.
The Sage Group
Why Sage?
About
Track Record
Locations
Added Value
Sage Clients
Testimonials
SAGEIQ
Services
M & A
Licensing
Sage Global
Sage APAC
Sage China
Sage Japan
Sage India
Team
Meet Us!
News
Downloads
Contact
More
Use tab to navigate through the menu items.
Sage Group News
Serpin Pharma Partners with Dogwood Therapeutics to Develop and Commercialize SP16 as a Treatment for Cancer-Related Pain
Manassas, VA - Serpin Pharma is pleased to announce a strategic partnership with Dogwood Therapeutics to develop and commercialize SP16,...
Sage Group Advises Fabre-Kramer Pharma on Partnering Deal with Aytu Biopharma for EXXUA(TM), a Newly Approved and Innovative Treatment for Major Depressive Disorder
Aytu BioPharma Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics,...
Sage New Client: Notogen's Groundbreaking Regenerative Therapy for Degenerative Disc Disease
Sage Group's new client, Notogen, is a US registered company focused on a regenerative therapeutic, designated NTG-101, for treating...
PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PETACH TIKVA, Israel, March 11, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD ) (“PolyPid” or the “Company”), a late-stage...
1
2
3
4
5
bottom of page
%20(2).jpg)
